Literature DB >> 25199023

Differences in EBA in the first two days of standard anti-tuberculosis treatment in different geographic regions.

Charles M Bark1, Phineas Gitta2, John L Johnson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25199023      PMCID： PMC4415604          DOI： 10.5588/ijtld.13.0826

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  12 in total

1.  Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosis patients.

Authors:  Andreas H Diacon; Rodney Dawson; Madeleine Hanekom; Kim Narunsky; Stefan J Maritz; Amour Venter; Peter R Donald; Christo van Niekerk; Karl Whitney; Doris J Rouse; Martino W Laurenzi; Ann M Ginsberg; Melvin K Spigelman
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191

2.  The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis.

Authors:  P R Donald; F A Sirgel; F J Botha; H I Seifart; D P Parkin; M L Vandenplas; B W Van de Wal; J S Maritz; D A Mitchison
Journal:  Am J Respir Crit Care Med       Date:  1997-09       Impact factor: 21.405

3.  Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment.

Authors:  C M Bark; P Gitta; S Ogwang; M Nsereko; B A Thiel; W H Boom; K D Eisenach; M L Joloba; J L Johnson
Journal:  Int J Tuberc Lung Dis       Date:  2013-11       Impact factor: 2.373

4.  Sources of variation in studies of the early bactericidal activity of antituberculosis drugs.

Authors:  F Sirgel; A Venter; D Mitchison
Journal:  J Antimicrob Chemother       Date:  2001-02       Impact factor: 5.790

5.  Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis.

Authors:  John L Johnson; Emmanuel Ssekasanvu; Alphonse Okwera; Harriet Mayanja; Christina S Hirsch; Joseph G Nakibali; Dana Drzayich Jankus; Kathleen D Eisenach; W Henry Boom; Jerrold J Ellner; Roy D Mugerwa
Journal:  Am J Respir Crit Care Med       Date:  2003-04-17       Impact factor: 21.405

6.  Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients.

Authors:  A H Diacon; R Dawson; M Hanekom; K Narunsky; A Venter; N Hittel; L J Geiter; C D Wells; A J Paccaly; P R Donald
Journal:  Int J Tuberc Lung Dis       Date:  2011-07       Impact factor: 2.373

7.  Geographic differences in time to culture conversion in liquid media: Tuberculosis Trials Consortium study 28. Culture conversion is delayed in Africa.

Authors:  William R Mac Kenzie; Charles M Heilig; Lorna Bozeman; John L Johnson; Grace Muzanye; Denise Dunbar; Kenneth C Jost; Lois Diem; Beverly Metchock; Kathleen Eisenach; Susan Dorman; Stefan Goldberg
Journal:  PLoS One       Date:  2011-04-11       Impact factor: 3.240

8.  Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.

Authors:  Amina Jindani; Caroline J Doré; Denis A Mitchison
Journal:  Am J Respir Crit Care Med       Date:  2003-01-06       Impact factor: 21.405

9.  Variable host-pathogen compatibility in Mycobacterium tuberculosis.

Authors:  Sebastien Gagneux; Kathryn DeRiemer; Tran Van; Midori Kato-Maeda; Bouke C de Jong; Sujatha Narayanan; Mark Nicol; Stefan Niemann; Kristin Kremer; M Cristina Gutierrez; Markus Hilty; Philip C Hopewell; Peter M Small
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

10.  The influence of human N-acetyltransferase genotype on the early bactericidal activity of isoniazid.

Authors:  P R Donald; F A Sirgel; A Venter; D P Parkin; H I Seifart; B W van de Wal; C Werely; P D van Helden; J S Maritz
Journal:  Clin Infect Dis       Date:  2004-10-25       Impact factor: 9.079
View more
  2 in total

1.  Time Trends in Sputum Mycobacterial Load and Two-Day Bactericidal Activity of Isoniazid-Containing Antituberculosis Therapies.

Authors:  Veronique De Jager; Lize van der Merwe; Amour Venter; Peter R Donald; Andreas H Diacon
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

2.  Clinical evaluation of tuberculosis viability microscopy for assessing treatment response.

Authors:  Sumona Datta; Jonathan M Sherman; Marjory A Bravard; Teresa Valencia; Robert H Gilman; Carlton A Evans
Journal:  Clin Infect Dis       Date:  2014-12-23       Impact factor: 9.079
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.